| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.0077 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |